XML 71 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED FINANCIAL INFORMATION OF AMERIS BANCORP (PARENT COMPANY ONLY) (Tables)
12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Schedule of Condensed Balance Sheets
Condensed Balance Sheets
December 31, 2023 and 2022
(dollars in thousands)
20232022
Assets
Cash and due from banks$165,179 $153,099 
Investment in subsidiaries3,611,093 3,477,917 
Other assets29,898 19,896 
Total assets$3,806,170 $3,650,912 
Liabilities
Other liabilities$33,766 $23,985 
Other borrowings215,342 301,205 
Subordinated deferrable interest debentures130,315 128,322 
Total liabilities379,423 453,512 
Shareholders' equity3,426,747 3,197,400 
Total liabilities and shareholders' equity$3,806,170 $3,650,912 
Schedule of Condensed Statements of Income
Condensed Statements of Income
Years Ended December 31, 2023, 2022 and 2021
(dollars in thousands)
202320222021
Income
Dividends from subsidiaries$175,000 $50,000 $142,000 
Other income462 175 101 
Securities gains— 270 — 
Total income175,462 50,445 142,101 
Expense
Interest expense24,568 22,170 19,610 
Other expense13,858 11,154 13,031 
Total expense38,426 33,324 32,641 
Income before taxes and equity in undistributed income of subsidiaries137,036 17,121 109,460 
Income tax benefit10,738 8,553 6,878 
Income before equity in undistributed income of subsidiaries147,774 25,674 116,338 
Equity in undistributed income of subsidiaries121,331 320,866 260,575 
Net income$269,105 $346,540 $376,913 
Schedule of Condensed Statements of Cash Flows
Condensed Statements of Cash Flows
Years Ended December 31, 2023, 2022 and 2021
(dollars in thousands)
202320222021
OPERATING ACTIVITIES
Net income$269,105 $346,540 $376,913 
Adjustments to reconcile net income to net cash provided by operating activities:
Share-based compensation expense9,950 6,706 7,948 
Undistributed earnings of subsidiaries(121,331)(320,866)(260,575)
Decrease increase in interest payable(319)(961)(36)
(Increase) decrease in tax receivable3,021 8,596 (6,238)
Provision for deferred taxes(1,165)(649)1,694 
Gain on sale of other investments— (270)— 
Change attributable to other operating activities1,188 200 3,678 
Total adjustments(108,656)(307,244)(253,529)
Net cash provided by operating activities160,449 39,296 123,384 
INVESTING ACTIVITIES
Net (increase) decrease in other investments— 213 (4,500)
Investment in subsidiary— (65,000)— 
Net cash used in investing activities— (64,787)(4,500)
FINANCING ACTIVITIES
Purchase of treasury shares(20,346)(22,421)(9,439)
Dividends paid - common stock(41,649)(41,610)(41,798)
Repayment of other borrowings(86,850)— — 
Proceeds from exercise of stock options476 2,799 4,532 
Net cash used in by financing activities(148,369)(61,232)(46,705)
Net change in cash and cash equivalents12,080 (86,723)72,179 
Cash and cash equivalents at beginning of year153,099 239,822 167,643 
Cash and cash equivalents at end of year$165,179 $153,099 $239,822 
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the year for interest$24,887 $23,131 $19,646 
Cash received during the year for income taxes$(12,593)$(16,499)$(2,367)